IOL Chemicals Q4 FY26 Results: PAT Rs 53 Cr

IOL Chemicals Q4 FY26 results were declared on May 20, 2026. IOL Chemicals reported PAT of Rs 53 crore for the quarter ended March 31, 2026, up 70% YoY compared to Rs 31 crore in Q4 FY25. Revenue from operations stood at Rs 619 crore, up 17% YoY. Gross profit was Rs 72 crore (up 63% YoY). The results are on a Consolidated basis. IOL Chemicals is a Specialty Chemicals and APIs company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

IOL Chemicals Q4 FY26 Financial Highlights

Metric	Q4 FY26 (Rs Cr)	Q4 FY25 (Rs Cr)	YoY Change
Revenue	619	528	+17%
Gross Profit	72	44	+63%
Net Profit	53	31	+70%
Basis	Consolidated

Note: PAT +70% YoY to Rs 53 crore on revenue of Rs 619 crore (+17% YoY). Gross profit +63% to Rs 72 crore. Strong ibuprofen and speciality chemical demand. IOL Chemicals Q4 FY26 results declared May 20, 2026. Verify from BSE/NSE audited filings.

IOL Chemicals Q4 FY26 Performance Analysis

The IOL Chemicals Q4 FY26 results reflect the company’s operational performance in the January to March 2026 quarter. The quarter demonstrates a meaningful improvement in profitability. IOL Chemicals operates in the Specialty Chemicals and APIs space, a sector shaped by domestic consumption trends, input costs, and India’s macro environment in FY26.

The 70% YoY PAT growth in IOL Chemicals Q4 FY26 reflects operational improvements, better cost management, and revenue scale benefits.

Screen the best stocks on the Univest Screener.

Key Factors Driving IOL Chemicals Q4 FY26 Results

Revenue Performance in Q4 FY26

IOL Chemicals Q4 FY26 revenue of Rs 619 crore was up 17% YoY. The double-digit revenue growth reflects strong demand and market share gains in the Specialty Chemicals and APIs sector.

Profitability and Margin Trends

The IOL Chemicals Q4 FY26 PAT of Rs 53 crore (up 70% YoY) reflects strong operating leverage and margin expansion in the Specialty Chemicals and APIs business.

India Macro Tailwinds in Q4 FY26

The January to March 2026 quarter benefited from India’s GDP growth above 6.5%, strong government capital expenditure, and resilient urban and rural consumption. The RBI’s accommodative policy stance supported demand conditions across consumer and industrial sectors. For IOL Chemicals, operating in the Specialty Chemicals and APIs space, this macro environment provided a constructive demand backdrop during the quarter.

FY27 Outlook for IOL Chemicals

Following IOL Chemicals Q4 FY26 results, investors will track management commentary on FY27 revenue guidance, margin trajectory, capex plans, and competitive positioning. The Specialty Chemicals and APIs sector continues to benefit from India’s structural growth story, rising middle-class consumption, and infrastructure investment cycle.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on IOL Chemicals Q4 FY26

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.